ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.42
+4.41%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-43.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 24, 2026 | Grow Brian · officer: Chief Commercial Officer | M-Exempt | 958 | $1.24 |
| Mar 11, 2026 | Leibowitz Arthur S · director | Purchase | 5,000 | $2.68 |
| Mar 11, 2026 | Driscoll Michael Joseph · director | Purchase | 10,000 | $2.67 |
| Feb 20, 2026 | Francisco David · officer: Chief Financial Officer | A-Award | 195,312 | $0.00 |
| Feb 20, 2026 | Gillheeney Gary S. · director, officer: President and CEO | A-Award | 507,795 | $3.84 |
| Feb 20, 2026 | Cavorsi Robert · officer: Vice President, Strategy | A-Award | 16,290 | $0.00 |
| Feb 20, 2026 | Grow Brian · officer: Chief Commercial Officer | A-Award | 48,330 | $0.00 |
| Feb 20, 2026 | Montecalvo Antonio S. · officer: Vice President, Health Policy | A-Award | 23,162 | $3.84 |
| Feb 20, 2026 | Bilbo Patrick · officer: Chief Operating Officer | F-InKind | 16,212 | $3.84 |
| Feb 20, 2026 | Duraibabu Prathyusha · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Freedman Lori · officer: Chief Admin. and Legal Officer | A-Award | 42,780 | $0.00 |
| Feb 20, 2026 | Quintero Gilberto · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Bilbo Patrick · officer: Chief Operating Officer | A-Award | 120,267 | $3.84 |
| Feb 20, 2026 | Bilbo Patrick · officer: Chief Operating Officer | A-Award | 48,612 | $0.00 |
| Feb 20, 2026 | Francisco David · officer: Chief Financial Officer | A-Award | 43,602 | $0.00 |
| Feb 20, 2026 | Francisco David · officer: Chief Financial Officer | A-Award | 111,358 | $3.84 |
| Feb 20, 2026 | Cavorsi Robert · officer: Vice President, Strategy | A-Award | 53,452 | $3.84 |
| Feb 20, 2026 | Lustig Garrett · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Gillheeney Gary S. · director, officer: President and CEO | A-Award | 890,625 | $0.00 |
| Feb 20, 2026 | Freedman Lori · officer: Chief Admin. and Legal Officer | F-InKind | 14,267 | $3.84 |
| Feb 20, 2026 | Cavorsi Robert · officer: Vice President, Strategy | F-InKind | 5,432 | $3.84 |
| Feb 20, 2026 | Driscoll Michael Joseph · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Montecalvo Antonio S. · officer: Vice President, Health Policy | A-Award | 11,218 | $0.00 |
| Feb 20, 2026 | Giacomin Jon L · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Bilbo Patrick · officer: Chief Operating Officer | A-Award | 210,937 | $0.00 |
| Feb 20, 2026 | Leibowitz Arthur S · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Francisco David · officer: Chief Financial Officer | F-InKind | 14,541 | $3.84 |
| Feb 20, 2026 | Montecalvo Antonio S. · officer: Vice President, Health Policy | F-InKind | 3,741 | $3.84 |
| Feb 20, 2026 | Korfin Michele Ilene · director | A-Award | 48,828 | $0.00 |
| Feb 20, 2026 | Montecalvo Antonio S. · officer: Vice President, Health Policy | A-Award | 40,625 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 48Increased 89Reduced 82Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MORGAN STANLEY | Increased | 11,721,609 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 11,616,795 | May 15, 2026 |
| Soleus Capital Management, L.P. | Increased | 10,140,951 | Aug 11, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 10,085,951 | May 14, 2026 |
| BlackRock, Inc. | Increased | 7,249,528 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,899,751 | May 13, 2026 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | Reduced | 3,498,533 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 3,050,297 | Aug 11, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,011,753 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,905,919 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,900,816 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,891,006 | May 7, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 2,888,313 | Aug 14, 2026 |
| D. E. SHAW & CO., INC. | Increased | 2,297,974 | May 15, 2026 |
| ASSENAGON ASSET MANAGEMENT S.A. | Reduced | 1,967,952 | Apr 20, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 24, 2026